Trevi Therapeutics (TRVI) Property, Plant & Equipment (Net) (2018 - 2026)

Trevi Therapeutics (TRVI) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 642,333.36
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 31.48 Mn
10 Trevi Therapeutics 2.54 Bn 2.54 Bn - 265,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 265,000.00
Mar 31, 2026 265,000.00
Dec 31, 2025 178,000.00
Dec 31, 2025 178,000.00
Sep 30, 2025 213,000.00
Sep 30, 2025 213,000.00
Jun 30, 2025 239,000.00
Jun 30, 2025 239,000.00
Mar 31, 2025 277,000.00
Mar 31, 2025 277,000.00
Dec 31, 2024 157,000.00
Dec 31, 2024 157,000.00
Sep 30, 2024 174,000.00
Sep 30, 2024 174,000.00
Jun 30, 2024 198,000.00
Jun 30, 2024 198,000.00
Mar 31, 2024 204,000.00
Mar 31, 2024 204,000.00
Dec 31, 2023 216,000.00
Dec 31, 2023 216,000.00